Regional cerebral blood flow (rCBF) was studied in nine patients with Alzheimer's disease before and after trestment with tacrine. A small but significant improvement in cognitive functioning on the drug was not accompanied by significant changes in rCBF for the group as a whole. However, when the a
THE EFFECTS OF POVERTY AND EDUCATION ON TEMPOROPARIETAL PERFUSION IN ALZHEIMER'S DISEASE: A RECONSIDERATION OF THE CEREBRAL RESERVE HYPOTHESIS
β Scribed by CARL I. COHEN; ARNOLD STRASHUN; CARLOS ORTEGA; LUCILLE HORN; CAROL MAGAI
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 555 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
β¦ Synopsis
The cerebral reserve hypothesis proposes that education may provide extra brain reserve that allows an individual to cope longer before Alzheimer's disease (AD) is expressed clinically. Studies of temporoparietal (TP) blood perfusion have been used to support this hypothesis. We reconsider the reserve hypothesis by examining various models of the effects of poverty and its relationship to education on TP perfusion. Of 41 patients with 'probable' AD, 63% evidenced TP hypoperfusion with SPECT. When each variable was examined separately, persons with lower education (OR = 4.40, 95% CI 1.09-17.73, p = 0.04) and poverty (OR = 5.43, 95% CI 1.37-21.62, p = 0.02) were significantly less likely to have TP hypoperfusion. However, neither variable had independent effects when tested simultaneously. Neither additive (poverty +education) nor interactive (poverty x education) explanatory models of TP hypoperfusion had any additional significant explanatory power. The findings suggest that the conclusion that higher education provides a protective effect in AD may be premature, and that there is equally compelling evidence that lower education and/or poverty may diminish cerebral reserve.
π SIMILAR VOLUMES
A Memory Clinic model set up to diagnose and treat Alzheimer's Disease early in the course of the illness delayed time to institutionalisation by a median of 9 months compared to controls. Treatment included pre and post diagnostic counselling, and psychosocial interventions.
## Abstract ## Background The use of cholinesterase inhibiors for Alzheimer's disease (AD) is currently being appraised by the National Institute for Clintical Evidence (NICE). This article provides the latest evidence that NICE will be using as part of this appraisal process. ## Objective To pr